Now available: Coronavirus SARS-CoV-2 Antigens
New recombinant SARS-CoV-2 antigens complement the growing SERION Immunologics raw material portfolio for IVD assay development.
Current News from our Company
New recombinant SARS-CoV-2 antigens complement the growing SERION Immunologics raw material portfolio for IVD assay development.
Learn more about our growing antigen product range! More coming soon...